230 related articles for article (PubMed ID: 17219217)
1. Cognitive, psychomotor and actual driving performance in healthy volunteers after immediate and extended release formulations of alprazolam 1 mg.
Leufkens TR; Vermeeren A; Smink BE; van Ruitenbeek P; Ramaekers JG
Psychopharmacology (Berl); 2007 May; 191(4):951-9. PubMed ID: 17219217
[TBL] [Abstract][Full Text] [Related]
2. Effects of alprazolam on driving ability, memory functioning and psychomotor performance: a randomized, placebo-controlled study.
Verster JC; Volkerts ER; Verbaten MN
Neuropsychopharmacology; 2002 Aug; 27(2):260-9. PubMed ID: 12093599
[TBL] [Abstract][Full Text] [Related]
3. Alprazolam absorption kinetics affects abuse liability.
Mumford GK; Evans SM; Fleishaker JC; Griffiths RR
Clin Pharmacol Ther; 1995 Mar; 57(3):356-65. PubMed ID: 7697954
[TBL] [Abstract][Full Text] [Related]
4. Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem.
Leufkens TR; Lund JS; Vermeeren A
J Sleep Res; 2009 Dec; 18(4):387-96. PubMed ID: 19552733
[TBL] [Abstract][Full Text] [Related]
5. Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers.
Otmani S; Demazières A; Staner C; Jacob N; Nir T; Zisapel N; Staner L
Hum Psychopharmacol; 2008 Dec; 23(8):693-705. PubMed ID: 18763235
[TBL] [Abstract][Full Text] [Related]
6. A double-blind, placebo- and positive-internal-controlled (alprazolam) investigation of the cognitive and psychomotor profile of pregabalin in healthy volunteers.
Hindmarch I; Trick L; Ridout F
Psychopharmacology (Berl); 2005 Dec; 183(2):133-43. PubMed ID: 16205916
[TBL] [Abstract][Full Text] [Related]
7. A single-center, randomized, double-blind, placebo-controlled, crossover investigation of the effects of fexofenadine hydrochloride 180 mg alone and with alcohol, with hydroxyzine hydrochloride 50 mg as a positive internal control, on aspects of cognitive and psychomotor function related to driving a car.
Ridout F; Shamsi Z; Meadows R; Johnson S; Hindmarch I
Clin Ther; 2003 May; 25(5):1518-38. PubMed ID: 12867226
[TBL] [Abstract][Full Text] [Related]
8. Absence of neuropsychologic deficits in patients receiving long-term treatment with alprazolam-XR for panic disorder.
Gladsjo JA; Rapaport MH; McKinney R; Auerbach M; Hahn T; Rabin A; Oliver T; Haze A; Judd LL
J Clin Psychopharmacol; 2001 Apr; 21(2):131-8. PubMed ID: 11270908
[TBL] [Abstract][Full Text] [Related]
9. The speed of onset of action of alprazolam-XR compared to alprazolam-CT in panic disorder.
Sheehan DV; Sheehan KH; Raj BA
Psychopharmacol Bull; 2007; 40(2):63-81. PubMed ID: 17514187
[TBL] [Abstract][Full Text] [Related]
10. Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs.
Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
J Clin Psychopharmacol; 2006 Oct; 26(5):519-23. PubMed ID: 16974197
[TBL] [Abstract][Full Text] [Related]
11. Comparison of acute alprazolam (0.25, 0.50 and 1.0 mg) effects versus those of lorazepam 2 mg and placebo on memory in healthy volunteers using laboratory and telephone tests.
Vermeeren A; Jackson JL; Muntjewerff ND; Quint PJ; Harrison EM; O'Hanlon JF
Psychopharmacology (Berl); 1995 Mar; 118(1):1-9. PubMed ID: 7597114
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Chronic Alprazolam Intake on Memory, Attention, and Psychomotor Performance in Healthy Human Male Volunteers.
Chowdhury ZS; Morshed MM; Shahriar M; Bhuiyan MA; Islam SM; Bin Sayeed MS
Behav Neurol; 2016; 2016():3730940. PubMed ID: 27462136
[TBL] [Abstract][Full Text] [Related]
13. Do alprazolam-induced changes in saccadic eye movement and psychomotor function follow the same time course?
Kroboth PD; Folan MM; Bauer KS; Tullock W; Wright CE; Sweeney JA
J Clin Pharmacol; 1998 Apr; 38(4):337-46. PubMed ID: 9590461
[TBL] [Abstract][Full Text] [Related]
14. Alprazolam extended-release in panic disorder.
Rickels K
Expert Opin Pharmacother; 2004 Jul; 5(7):1599-611. PubMed ID: 15212610
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of alprazolam on the baseline and fear-potentiated startle reflex in humans: a dose-response study.
Riba J; Rodríguez-Fornells A; Urbano G; Morte A; Antonijoan R; Barbanoj MJ
Psychopharmacology (Berl); 2001 Oct; 157(4):358-67. PubMed ID: 11605094
[TBL] [Abstract][Full Text] [Related]
16. Comparing the effects of oxazepam and diazepam in actual highway driving and neurocognitive test performance: a validation study.
Jongen S; Vuurman EFPM; Ramaekers JG; Vermeeren A
Psychopharmacology (Berl); 2018 Apr; 235(4):1283-1294. PubMed ID: 29500585
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of quetiapine extended-release and quetiapine immediate-release on cognitive performance, sedation and patient satisfaction in patients with schizophrenia: a randomised, double-blind, crossover study (eXtRa).
Riedel M; Schmitz M; Østergaard PK; Ferrannini L; Franco MA; Alfano V; Vansvik ED
Schizophr Res; 2015 Mar; 162(1-3):162-8. PubMed ID: 25592805
[TBL] [Abstract][Full Text] [Related]
18. Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance.
Verster JC; Volkerts ER; Schreuder AH; Eijken EJ; van Heuckelum JH; Veldhuijzen DS; Verbaten MN; Paty I; Darwish M; Danjou P; Patat A
J Clin Psychopharmacol; 2002 Dec; 22(6):576-83. PubMed ID: 12454557
[TBL] [Abstract][Full Text] [Related]
19. Effects of buspirone and alprazolam on the cognitive performance of normal elderly subjects.
Hart RP; Colenda CC; Hamer RM
Am J Psychiatry; 1991 Jan; 148(1):73-7. PubMed ID: 1984710
[TBL] [Abstract][Full Text] [Related]
20. A method for determining the magnitude of change across different cognitive functions in clinical trials: the effects of acute administration of two different doses alprazolam.
Snyder PJ; Werth J; Giordani B; Caveney AF; Feltner D; Maruff P
Hum Psychopharmacol; 2005 Jun; 20(4):263-73. PubMed ID: 15912482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]